DNA copy number variation and gene expression analyses reveal the implication of specific oncogenes and genes in GBM

Cancer Investigation

Volumn 27, Issue 5, 2009, Pages 541-548

  Margareto, Javier ^a   Leis, Olatz ^b,c   Larrarte, Eider ^a   Pomposo, Iñigo C ^b,c   Garibi, Jesús María ^b,c   Lafuente, Jose Vicenté ^c  

^a TECNALIA RESEARCH AND INNOVATION   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

CGH array; Copy number gains; Gene expression; Glioblastoma

Indexed keywords

DNA; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 9; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; CHROMOSOME ABERRATION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN CHROMOSOME; MIDDLE AGED;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; TUMOR MARKERS, BIOLOGICAL;

EID: 67449106767     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802563044     Document Type: Article

References (43)

1. Schwartzbaum, J.A.; Fisher, J.L.; Aldape, K.D.; Wrensch, M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006, 2, 494-503; quiz 491 p following 516.
2. Louis, D.N.; Ohgaki, H.; Wiestler, O.D.; Cavenee, W.K.; Burger, P.C.; Jouvet, A.; Scheithauer, B.W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114, 97-109.
3. Gudinaviciene, I.; Pranys, D.; Juozaityte, E. Impact of morphology and biology on the prognosis of patients with gliomas. Medicina (Kaunas) 2004, 40, 112-120.
4. Margareto, J.; Leis, O.; Larrarte, E.; Idoate, M.A.; Carrasco, A.; Lafuente, J.V. Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways. J Mol Neurosci 2007, 32, 53-63.
5. Wolf, M.; Mousses, S.; Hautaniemi, S.; Karhu, R.; Huusko, P.; Allinen, M.; Elkahloun, A.; Monni, O.; Chen, Y.; Kallioniemi, A.; Kallioniemi, O.P. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia 2004, 6, 240-247.
6. Ruano, Y.; Mollejo, M.; Ribalta, T.; Fiano, C.; Camacho, F.I.; Gomez, E.; de Lope, A.R.; Hernandez-Moneo, J.L.; Martinez, P.; Melendez, B. Identification of novel candidate target genes in amplicons of glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer 2006, 5, 39. (Pubitemid 44541842)
7. Burton, E.C.; Lamborn, K.R.; Feuerstein, B.G.; Prados, M.; Scott, J.; Forsyth, P.; Passe, S.; Jenkins, R.B.; Aldape, K.D. Genetic aberrations defined by comparative genomic hybridization distinguish long-termfrom typical survivors of glioblastoma. Cancer Res 2002, 62, 6205-6210.
8. Inda, M.M.; Fan, X.; Munoz, J.; Perot, C.; Fauvet, D.; Danglot, G.; Palacio, A.; Madero, P.; Zazpe, I.; Portillo, E.; Tunon, T.; Martinez-Penuela, J.M.; Alfaro, J.; Eiras, J.; Bernheim, A.; Castresana, J.S. Chromosomal abnormalities in human glioblastomas: gain in chromosome 7p correlating with loss in chromosome 10q. Mol Carcinog 2003, 36, 6-14.
9. Saigusa, K.; Hashimoto, N.; Tsuda, H.; Yokoi, S.; Maruno, M.; Yoshimine, T.; Aoyagi, M.; Ohno, K.; Imoto, I.; Inazawa, J. Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas. Cancer Sci 2005, 96, 676-683. (Pubitemid 41723544)
10. Diskin, S.J.; Eck, T.; Greshock, J.; Mosse, Y.P.; Naylor, T.; Stoeckert, C.J., Jr.; Weber, B.L.; Maris, J.M.; Grant, G.R. STAC: a method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. Genome Res 2006, 16, 1149-1158.
11. Nemeth, J.A.; Nakada, M.T.; Trikha, M.; Lang, Z.; Gordon, M.S.; Jayson, G.C.; Corringham, R.; Prabhakar, U.; Davis, H.M.; Beckman, R.A. Alpha-v integrins as therapeutic targets in oncology. Cancer Invest 2007, 25, 632-646. (Pubitemid 350135743)
12. Hsu, A.R.; Veeravagu, A.; Cai, W.; Hou, L.C.; Tse, V.; Chen, X. Integrin alpha (v)beta (3) antagonists for anti-angiogenic cancer treatment. Recent Patents Anticancer Drug Discov 2007, 2, 143-158.
13. Mischel, P.S.; Cloughesy, T.F.; Nelson, S.F. DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci 2004, 5, 782-792.
14. Martins, C.M.; Fernandes, B.F.; Antecka, E.; Di Cesare, S.; Mansure, J.J.; Marshall, J.C.; Burnier, M.N., Jr. Expression of the metastasis suppressor gene KISS1 in uveal melanoma. Eye 2008. May; 22(5), 707-711.
15. Guan-Zhen, Y.; Ying, C.; Can-Rong, N.; Guo-Dong, W.; Jian-Xin, Q.; Jie-Jun, W. Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer. Int J Exp Pathol 2007, 88, 175-183. (Pubitemid 46743980)
16. Ohta, S.; Lai, E.W.; Pang, A.L.; Brouwers, F.M.; Chan, W.Y.; Eisenhofer, G.; de Krijger, R.; Ksinantova, L.; Breza, J.; Blazicek, P.; Kvetnansky, R.; Wesley, R.A.; Pacak, K. Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer 2005, 114, 139-143. (Pubitemid 40194319)
17. Goldberg, S.F.; Miele, M.E.; Hatta, N.; Takata, M.; Paquette-Straub, C.; Freedman, L.P.; Welch, D.R. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 2003, 63, 432-440.
18. Le Jan, S.; LeMeur, N.; Cazes, A.; Philippe, J.; Le Cunff, M.; Leger, J.; Corvol, P.; Germain, S. Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer. FEBS Lett 2006, 580, 3395-3400.
19. Gaiano, N.; Fishell, G. The role of notch in promoting glial and neural stem cell fates. Annu Rev Neurosci 2002, 25, 471-490. (Pubitemid 34748025)
20. Gil-Benso, R.; Lopez-Gines, C.; Benito, R.; Lopez-Guerrero, J.A.; Callaghan, R.C.; Pellin, A.; Roldan, P.; Cerda-Nicolas, M. Concurrent EGFR amplification and TP-53 mutation in glioblastomas. Clin Neuropathol 2007, 26, 224-231. (Pubitemid 47403417)
21. Nigro, J.M.; Misra, A.; Zhang, L.; Smirnov, I.; Colman, H.; Griffin, C.; Ozburn, N.; Chen, M.; Pan, E.; Koul, D.; Yung, W.K.; Feuerstein, B.G.; Aldape, K.D. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 2005, 65, 1678-1686.
22. Jozwiak, J.; Kotulska, K.; Grajkowska, W.; Jozwiak, S.; Zalewski, W.; Oldak, M.; Lojek, M.; Rainko, K.; Maksym, R.; Lazarczyk, M.; Skopinski, P.; Wlodarski, P. Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas. Brain Dev 2007, 29, 273-280. (Pubitemid 46483917)
23. Yokota, N.; Nishizawa, S.; Ohta, S.; Date, H.; Sugimura, H.; Namba, H.; Maekawa, M. Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 2002, 101, 198-201. (Pubitemid 34970914)
24. Christner, P.J.; Ayitey, S. Extracellular matrix containing mutated fibrillin-1 (Fbn1) down regulates Col1a1, Col1a2, Col3a1, Col5a1, and Col5a2 mRNA levels in Tsk/+ and Tsk/Tsk embryonic fibroblasts. Amino Acids 2006, 30, 445-451. (Pubitemid 43886905)
25. Rocha, R.L.; Hilsenbeck, S.G.; Jackson, J.G.; Lee, A.V.; Figueroa, J.A.; Yee, D. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 1996, 88, 601-606. (Pubitemid 26137582)
26. Reichardt, W.; Jung, V.; Brunner, C.; Klein, A.; Wemmert, S.; Romeike, B.F.; Zang, K.D.; Urbschat, S. The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Oncol Rep 2003, 10, 1275-1279.
27. Nowee, M.E.; Dorsman, J.C.; Piek, J.M.; Kosma, V.M.; Hamalainen, K.; Verheijen, R.H.; van Diest, P.J. HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study. Histopathology 2007, 51, 666-673.
28. Zamostiano, R.; Pinhasov, A.; Gelber, E.; Steingart, R.A.; Seroussi, E.; Giladi, E.; Bassan, M.; Wollman, Y.; Eyre, H.J.; Mulley, J.C.; Brenneman, D.E.; Gozes, I. Cloning and characterization of the human activity-dependent neuroprotective protein. J Biol Chem 2001, 276, 708-714. (Pubitemid 32050368)
29. Zhou, Y.H.; Hess, K.R.; Liu, L.; Linskey, M.E.; Yung, W.K. Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables. Neuro-Oncol 2005, 7, 485-494.
30. Reifenberger, G.; Ichimura, K.; Reifenberger, J.; Elkahloun, A.G.; Meltzer, P.S.; Collins, V.P. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 1996, 56, 5141-5145.
31. Rollbrocker, B.; Waha, A.; Louis, D.N.; Wiestler, O.D.; von Deimling, A. Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol 1996, 92, 70-74.
32. Darwish, H.; Cho, J.M.; Loignon, M.; Alaoui-Jamali, M.A. Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth. Oncogene 2007, 26, 4319-4328.
33. Nakahara, S.; Raz, A. Biological modulation by lectins and their ligands in tumor progression and metastasis. Anticancer Agents Med Chem 2008, 8, 22-36.
34. Langbein, S.; Brade, J.; Badawi, J.K.; Hatzinger, M.; Kaltner, H.; Lensch, M.; Specht, K.; Andre, S.; Brinck, U.; Alken, P.; Gabius, H.J. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 2007, 51, 681-690.
35. Garcia, J.A. HIFing the brakes: therapeutic opportunities for treatment of human malignancies. Sci STKE 2006, 2006, pe25.
36. Li, Q.F.; Wang, X.R.; Yang, Y.W.; Lin, H. Hypoxia upregulates hypoxia inducible factor (HIF)-3alpha expression in lung epithelial cells: characterization and comparison with HIF-1alpha. Cell Res 2006, 16, 548-558. (Pubitemid 43920283)
37. Ertekin-Taner, N. Genetics of Alzheimer's disease: a centennial review. Neurol Clin 2007, 25, 611-667, v. (Pubitemid 47058875)
38. Bach-Ngohou, K.; Nazih, H.; Nazih-Sanderson, F.; Zair, Y.; Le Carrer, D.; Krempf, M.; Bard, J.M. Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo. Int J Obes Relat Metab Disord 2001, 25, 1752-1758.
39. Nicoll, J.A.; Zunarelli, E.; Rampling, R.; Murray, L.S.; Papanastassiou, V.; Stewart, J. Involvement of apolipoprotein E in glioblastoma: immunohistochemistry and clinical outcome. Neuroreport 2003, 14, 1923-1926. (Pubitemid 38339761)
40. Mahadevan, D.; Cooke, L.; Riley, C.; Swart, R.; Simons, B.; Della Croce, K.; Wisner, L.; Iorio, M.; Shakalya, K.; Garewal, H.; Nagle, R.; Bearss, D. A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene 2007, 26, 3909-3919. (Pubitemid 46884299)
41. Sawabu, T.; Seno, H.; Kawashima, T.; Fukuda, A.; Uenoyama, Y.; Kawada, M.; Kanda, N.; Sekikawa, A.; Fukui, H.; Yanagita, M.; Yoshibayashi, H.; Satoh, S.; Sakai, Y.; Nakano, T.; Chiba, T. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog 2007, 46, 155-164. (Pubitemid 46272123)
42. Hutterer, M.; Knyazev, P.; Abate, A.; Reschke, M.; Maier, H.; Stefanova, N.; Knyazeva, T.; Barbieri, V.; Reindl, M.; Muigg, A.; Kostron, H.; Stockhammer, G.; Ullrich, A. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res 2008, 14, 130-138.
43. Balesaria, S.; Brock, C.; Bower, M.; Clark, J.; Nicholson, S.K.; Lewis, P.; de Sanctis, S.; Evans, H.; Peterson, D.; Mendoza, N.; Glaser, M.G.; Newlands, E.S.; Fisher, R.A. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. Br J Cancer 1999, 81, 1371-1377.